Abstract
So far, study protocols are being worked out in confidence and acceptable benchmarks are being set during technical briefings attended only by industry representatives and the odd health professional.
| Original language | Canadian English |
|---|---|
| Publication status | Published - Jan. 1 2020 |
Keywords
- COVID-19
- vaccines
- Canada
Disciplines
- Food and Drug Law
- Health Law and Policy
- Law
- Science and Technology Law